Coverage
-
September 01, 2022
Eli Lilly and Co. has asked an Illinois federal judge to unwind a jury's $61 million verdict in a whistleblower's suit claiming the drug company intentionally shorted Medicaid on drug rebates, arguing the whistleblower can't prove the company knowingly violated the law.
4 other articles on this case.
View all »